AIM ImmunoTech (AIM)

P/S ratio as of November 2026 (TTM): 66.6

According to AIM ImmunoTech 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.95. At the end of 2023 the company had a P/S ratio of 115.

P/S ratio history for AIM ImmunoTech from 2001 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	115	7.11%
2022	107	-67.39%
2021	329	-26.47%
2020	447	1007.04%
2019	40.4	67.92%
2018	24.0	-4.74%
2017	25.2	-86.04%
2016	181	20.62%
2015	150	-42.12%
2014	259	-13.11%
2013	298	52%
2012	196	19.33%
2011	164	-66.16%
2010	485	-27.54%
2009	670	537.08%
2008	105	99.03%
2007	52.8	-66.47%
2006	158	39.75%
2005	113	45.1%
2004	77.7	-42.18%
2003	134	-32.99%
2002	201	-45.79%
2001	370

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
OPKO Health OPK	2.16	-96.76%	🇺🇸 USA
Onconova Therapeutics ONTX	92.5	38.82%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for AIM ImmunoTech (AIM)

P/S ratio as of November 2026 (TTM): 66.6